Medtech Big 100 revenue hit a new record high, but collective R&D spending by the world’s largest medical device companies is leveling off. By Managing Editor Jim Hammerand and Senior Editor Danielle Kirsh Aggregate research and development spending growth across the world’s largest medical device companies is grinding to a halt after double-digit growth in…
What Medtronic learned on its long road to RDN approval
It took Medtronic nearly 13 years to win FDA approval for renal denervation (RDN) since buying Ardian and its hypertension-treating technology. Jason Weidman, the Medtronic SVP who is also president of coronary and RDN, has a more personal measure of the long road to approval for the world’s largest medical device manufacturer. “The first meeting…